BEUDAMED
    390 results · 23ms · Sources: EU EUDAMED, US FDA
    Filters Classification: FDA Class 2 ×

    System, Nuclear Magnetic Resonance Imaging

    FDA Pre-Market Approval
    FDA Class 2 ·DIASONICS NMR IMAGING SYSTEM

    System, Nuclear Magnetic Resonance Imaging

    FDA Pre-Market Approval
    FDA Class 2 ·DIASONICS NMR IMAGING SYSTEM

    System, Nuclear Magnetic Resonance Imaging

    FDA Pre-Market Approval
    FDA Class 2 ·DIASONICS NMR IMAGING SYSTEM

    Lens, Contact (Other Material) - Daily

    FDA Pre-Market Approval
    FDA Class 2 ·OCUSIL(TM) CONTACT LENS

    Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers

    FDA Pre-Market Approval
    FDA Class 2 ·ST AIA-PACK PA

    Lens, Contact (Other Material) - Daily

    FDA Pre-Market Approval
    FDA Class 2 ·OCUSIL(TM) CONTACT LENS

    Over-The-Counter Molecular Test To Detect Sars-Cov-2 From Clinical Specimens

    FDA classification
    FDA Class 2 ·Over-The-Counter Molecular Test To Detect Sars-Cov-2 From Clinical Specimens

    Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents

    FDA classification
    FDA Class 2 ·Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents

    Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings

    FDA classification
    FDA Class 2 ·Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings

    Simple Point-Of-Care Device To Detect Sar-Cov-2 Nucleic Acid Targets From Clinical Specimens In Near-Patient Settings

    FDA classification
    FDA Class 2 ·Simple Point-Of-Care Device To Detect Sar-Cov-2 Nucleic Acid Targets From Clinical Specimens In Near-Patient Settings